FDA Approved: IMIPRAMINE PAMOATE — Supplemental Application (Hikma Pharmaceuticals USA Inc)

View source ↗

Summary

The FDA approved a supplemental application for Imipramine Pamoate by Hikma Pharmaceuticals USA Inc, indicating an approved change to an existing product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Enuresis
• Major Depressive Disorder

Drugs mentioned

• Imipramine Pamoate (Imipramine pamoate)

Snippet

SUPPL AP for IMIPRAMINE PAMOATE (IMIPRAMINE PAMOATE)